<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139438">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01285765</url>
  </required_header>
  <id_info>
    <org_study_id>LNH 2009-1B</org_study_id>
    <nct_id>NCT01285765</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Non-inferiority of a Treatment Adapted to the Early Response Evaluated With 18F-FDG PET Compared to a Standard Treatment, for Patients Aged From 18 to 80 Years With Low Risk (aa IPI = 0) Diffuse Large B-cells Non Hodgkin's Lymphoma CD 20+</brief_title>
  <official_title>Randomized Phase III Study Evaluating the Non-inferiority of a Treatment Adapted to the Early Response Evaluated With 18F-FDG PET Compared to a Standard Treatment, for Patients Aged From 18 to 80 Years With Low Risk (aa IPI = 0) Diffuse Large B-cells Non Hodgkin's Lymphoma CD 20+</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Lymphoma Academic Research Organisation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHU de Nancy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Lymphoma Academic Research Organisation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Localized stages DLBCL with low IPI (aaIPI = 0) have a very good prognostic after a standard
      immuno-chemotherapy with 6 cycles of R-CHOP 21. Five years PFS is estimated over 75%,
      whatever the age of the patient.

      PET scan is actually considered as &quot;the gold standard&quot; for the initial staging and the
      evaluation of response after treatment. With this new technique, the response criteria have
      been redefined by Cheson and al. in 2007. Moreover, several recent studies showed that early
      evaluation of response with PET scan after only 2 cycles of chemotherapy was accurate to
      define two groups of patients:

      &quot;Early-good-responders&quot;, when PET scan is negative &quot;Early-poor-responders&quot;, when PET scan
      remains positive Prognostic for the first group is very good, and for the second poorer. At
      the present time, the interest of the modification and/or the intensification of the
      treatment for the early-poor-responder patients is not demonstrated by any publication. New
      studies are ongoing for patients with advanced stages of DLBC NHL (GELA trial LNH 07-3B) or
      Hodgkin's lymphoma (GELA and EORTC trial H10); the aim is to evaluate a new strategy of
      treatment adapted to early response criteria.

      No trial has already been made for low IPI DLBCL. In this study, the investigators purpose
      is to evaluate the adaptation of treatment with early response based on PET scan results
      after 2 cycles of chemotherapy, for patient aged from 18 to 80 years, with low IPI DLBCL.

      This is an open randomized study.

      The primary endpoint is to evaluate the 3 years PFS with the aim to demonstrate the non
      inferiority of the experimental arm in comparison to standard arm:

      In standard arm, the patients will receive 6 cycles of R-CHOP 21 without taking into account
      of PET scan results after 2 cycles.

      In experimental arm, early good responder patients (defined as having a negative PET scan
      after 2 cycles, confirmed after 4 cycles) will receive only 4 cycles of R-CHOP 21.

      In both arms, if the PET scan remains positive after 4 cycles of chemotherapy, a biopsy exam
      is needed to confirm the failure and an intensive chemotherapy is then recommended.

      All of the patients, in both arms, will have an early evaluation with PET scan. All PET scan
      will be reviewed by a group of expert according to Deauville criteria defined by Meignan et
      al to adapt the decision after the 2nd cycle in experimental arm and after the 4th cycle for
      all patients. The final evaluation of response will be made according to 2007 Cheson's
      criteria.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression Free Survival</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluate by PFS at 3 years the non-inferiority of a chemotherapy treatment with 4 or 6 cycles of R-CHOP 21, determined according to early response assessed by PET at the end of 2 cycles versus standard chemotherapy of 6 cycles of R-CHOP 21 in patients with DLBCL lymphoma CD20+ with no factors of the IPI age adjusted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DELTA SUV</measure>
    <time_frame>3 weeks post C4 last patient</time_frame>
    <description>Determine the decrease of SUV max between PET at baseline, PET after cycle 2 and PET after cycle 4 and evaluate the changes predictive interest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival, EFS, response duration, DFS</measure>
    <time_frame>3 years</time_frame>
    <description>Assess the overall survival, the EFS (Event Free Survival - events defined as death from any cause, relapse for complete responders and undocumented complete responders, progression during or after treatment, initiation of a new anti-lymphoma therapy), the response duration, and the DFS for complete responders (disease free survival).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prognostic impact of the existence of a high tumor burden at diagnosis (&gt; 10 cm) on PFS</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluate the prognostic impact of the existence of a high tumor burden at diagnosis (&gt; 10 cm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biological factors</measure>
    <time_frame>3 weeks post last cycle and 3years survival</time_frame>
    <description>Identify the biological factors on blood samples and on tumor biopsy influencing the patient treatment response and prognosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Response Rate</measure>
    <time_frame>3 weeks post last cycle last patient</time_frame>
    <description>Evaluate the overall response rate according to IWC (International Harmonization Project - Cheson 2007) (CR, PR) after 4 or 6 cycles of R-CHOP21 according to the treatment arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of good responders according to results at PET after C2</measure>
    <time_frame>3 weeks post C2 last patient</time_frame>
    <description>Evaluate the rate of negative PET2</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">650</enrollment>
  <condition>DLBCL</condition>
  <arm_group>
    <arm_group_label>Early-PET-result-adapted treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 to 6 RCHOP21</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 RCHOP21</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RCHOP21</intervention_name>
    <description>Prednisone-60 mg/m2: D1 D2 D3 D4 D5;Rituximab-375 mg/m2 : D1; Doxorubicin-50 mg/m2 D1;Cyclophosphamide-750 mg/m2:D1 Vincristine-1.4 mg/m2 :D1; G-CSF SC -5 microg/kg/day: D6 to D13</description>
    <arm_group_label>Early-PET-result-adapted treatment</arm_group_label>
    <arm_group_label>standard treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with histologically proven CD20+ diffuse large B-cell lymphoma (DLBCL) (WHO
             classification 2008) including clinical subtypes (primitive mediastinal,
             intravascular, etc.). Patients with De Novo Transformed DLBCL from low grade lymphoma
             (Follicular, other...) may also be included; or CD20+ B-cell lymphoma with
             intermediate features between DLBCL and Burkitt; or with intermediate features
             between DLBCL and classical Hodgkin lymphoma; or CD20+ Follicular lymphoma grade 3B;
             or CD20+ Aggressive B-cell lymphoma unclassifiable.

          -  Age from18 to 80 years.

          -  Patient not previously treated.

          -  Ann Arbor Stage : I or II.

          -  Normal level of LDH.

          -  ECOG performance status (PS) &lt; 2.

          -  Age-adjusted international prognostic index (aaIPI) = 0.

          -  Baseline PET (PET0) performed before any treatment, even in absence of known lesion
             (for stage I for which the lesion has been removed for diagnostic reason).

          -  Having previously signed a written informed consent.

          -  The subject must be covered by a social security system (in France).

        Exclusion Criteria:

          -  Any other histological type of lymphoma, Burkitt included.

          -  Any history of treated or non-treated small B-cell lymphoma.

          -  Central nervous system or meningeal involvement by lymphoma.

          -  Contra-indication to any drug contained in the chemotherapy regimens.

          -  Poor renal function (creatinin level &gt;150 mmol/L), poor hepatic function (total
             bilirubin level &gt;30 mmol/L, transaminases &gt;2.5 ULN) unless these abnormalities are
             related to the lymphoma.

          -  Poor bone marrow reserve as defined by Absolute Neutrophils Count (ANC) &lt;1.5 G/L or
             platelets &lt;100 G/L, unless related to bone marrow infiltration.

          -  Any history of cancer during the last 5 years with the exception of non-melanoma skin
             tumors or stage 0 (in situ) cervical carcinoma.

          -  Any serious active disease (according to the investigator's decision).

          -  Positive HIV, HBV and HCV serologies before inclusion (except after hepatitis B
             vaccination or for patients who are HBs Ag negative, anti-HBs positive and/or
             anti-HBc positive but viral DNA negative).

          -  Treatment with any investigational drug within 30 days before planned first cycle of
             chemotherapy.

          -  Pregnant or lactating women or women of childbearing potential not currently
             practicing an adequate method of contraception.

          -  Adult patient under tutelage.

          -  Impossibility to perform a baseline PET scan (PET0) before randomization and
             treatment start.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge Bologna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brabois -Vandoeuvre les Nancy -France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Noël BASTIE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Dijon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serge BOLOGNA</last_name>
    <email>s.bologna@chu-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Noël BASTIE</last_name>
    <email>jean-noel.bastie@chu-dijon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ZNA Stuivenberg</name>
      <address>
        <city>Antwerpen</city>
        <zip>2060</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ka Lung WU, MD</last_name>
      <email>kalung.wu@zna.be</email>
    </contact>
    <investigator>
      <last_name>Ka Lung WU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A. Z. Sint-Jan</name>
      <address>
        <city>Bruges</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Achiel VAN HOOF, MD</last_name>
      <email>Achiel.VanHoof@azsintjan.be</email>
    </contact>
    <investigator>
      <last_name>Achiel VAN HOOF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Bruxelles</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique BRON, MD</last_name>
      <email>dominique.bron@bordet.be</email>
    </contact>
    <investigator>
      <last_name>Dominique BRON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Libre de Bruxelles - Hôpital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie DE WILDE, MD</last_name>
      <email>virginie.de.wilde@ulb.ac.be</email>
    </contact>
    <investigator>
      <last_name>Virginie DE WILDE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Catholique de Louvain Saint Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric VAN DEN NESTE, MD</last_name>
      <email>eric.vandenneste@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Eric VAN DEN NESTE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grand Hôpital de Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine PRANGER, MD</last_name>
      <email>delphine.pranger@ghdc.be</email>
    </contact>
    <investigator>
      <last_name>Delphine PRANGER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fritz OFFNER, MD</last_name>
      <email>fritz.offner@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Fritz OFFNER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Jolimont</name>
      <address>
        <city>Haine Saint Paul</city>
        <zip>7100</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole STRAETMANS, MD</last_name>
      <email>nicole.straetmans@scarlet.be</email>
    </contact>
    <investigator>
      <last_name>Nicole STRAETMANS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe BONNET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christophe BONNET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Joseph</name>
      <address>
        <city>Mons</city>
        <zip>7000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique BOULET, MD</last_name>
      <email>dominique.boulet@chr-afic.be</email>
    </contact>
    <investigator>
      <last_name>Dominique BOULET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Pierre</name>
      <address>
        <city>Ottignies</city>
        <zip>1340</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry CONNEROTTE, MD</last_name>
      <email>th.connerotte@clinique-saint-pierre.be</email>
    </contact>
    <investigator>
      <last_name>Thierry CONNEROTTE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Wallonie Picarde - CHwapi</name>
      <address>
        <city>Tournai</city>
        <zip>7500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khalil KARGAR SAMANI, MD</last_name>
      <email>khalil.kargarsamani@chwapi.be</email>
    </contact>
    <investigator>
      <last_name>Khalil KARGAR SAMANI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Tourelle-Peltzer</name>
      <address>
        <city>Verviers</city>
        <zip>4800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaetan VANSTRAELEN, MD</last_name>
      <email>gaetan.vanstraelen@chplt.be</email>
    </contact>
    <investigator>
      <last_name>Gaetan VANSTRAELEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCL Mont Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc ANDRE, MD</last_name>
      <email>marc.andre@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Marc ANDRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Pierre MOLES-MOREAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie-Pierre MOLES-MOREAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Antibes</name>
      <address>
        <city>Antibes</city>
        <zip>06606</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Victor Dupouy</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Driss CHAOUI, MD</last_name>
      <email>driss.chaoui@ch-argenteuil.fr</email>
    </contact>
    <investigator>
      <last_name>Driss CHAOUI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'ARRAS</name>
      <address>
        <city>Arras</city>
        <zip>62022</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline LIONNE-HUYGUE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pauline LIONNE-HUYGUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Avignon</name>
      <address>
        <city>Avignon</city>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hacene ZERAZHI, MD</last_name>
      <email>hzerazhi@ch-avignon.fr</email>
    </contact>
    <investigator>
      <last_name>Hacene ZERAZHI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne BANOS, MD</last_name>
      <email>abanos@ch-cotebasque.fr</email>
    </contact>
    <investigator>
      <last_name>Anne BANOS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon - Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrien CHAUCHET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Adrien CHAUCHET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié - Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fontanet BIJOU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fontanet BIJOU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord Aquitaine</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier FITOUSSI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier FITOUSSI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH du Dr Duchenne</name>
      <address>
        <city>Boulogne-sur-Mer</city>
        <zip>62200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bachra CHOUFI, MD</last_name>
      <email>b.choufi@ch-boulogne.fr</email>
    </contact>
    <investigator>
      <last_name>Bachra CHOUFI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Bourg-en-Bresse</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>01012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hubert ORFEUVRE, MD</last_name>
      <email>horfeuvre@ch-bourg01.fr</email>
    </contact>
    <investigator>
      <last_name>Hubert ORFEUVRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Brive</name>
      <address>
        <city>Brive-la-Gaillarde</city>
        <zip>19312</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>IHBN - CHU Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret MACRO, MD</last_name>
      <email>macro-m@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Margaret MACRO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Régis KAPHAN, MD</last_name>
      <email>r.kaphan@ch-cannes.fr</email>
    </contact>
    <investigator>
      <last_name>Régis KAPHAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Médipôle de Savoie</name>
      <address>
        <city>Challes-les-Eaux</city>
        <zip>73190</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selim CORM, MD</last_name>
      <email>selim.corm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Selim CORM, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Chalon</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <zip>71100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno SALLES, MD</last_name>
      <email>bruno.salles@ch-chalon71.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno SALLES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Chambéry</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gian Matteo PICA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gian Matteo PICA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital d'Instruction des Armées Percy</name>
      <address>
        <city>Clamart</city>
        <zip>92141</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BOUE, MD</last_name>
      <email>francois.boue@abc.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>François BOUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Estaing - Clermont Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier TOURNILHAC, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier TOURNILHAC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pasteur</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric KOHSER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric KOHSER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Compiègne</name>
      <address>
        <city>Compiègne</city>
        <zip>60321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe NACCACHE, MD</last_name>
      <email>p.naccache@ch-compiegne.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe NACCACHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Alpes Léman</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol ALLIOT, MD</last_name>
      <email>alliotcfr@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Carol ALLIOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Sud Francilien</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand JOLY, MD</last_name>
      <email>bertrand.joly@ch-sud-francilien.fr</email>
    </contact>
    <investigator>
      <last_name>Bertrand JOLY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri MONDOR</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne HAIOUN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Corinne HAIOUN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Noël BASTIE, MD</last_name>
      <email>Jean-noel.bastie@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Noël BASTIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Dunkerque</name>
      <address>
        <city>Dunkerque</city>
        <zip>59385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel PIGNON, MD</last_name>
      <email>jean-michel.pignon@ch-dunkerque.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel PIGNON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble - Hôpital Albert Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lysiane MOLINA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Lysiane MOLINA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Guéret</name>
      <address>
        <city>Guéret</city>
        <zip>23000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CH Départemental Vendée</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hervé MAISONNEUVE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hervé MAISONNEUVE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hassan FARHAT, MD</last_name>
      <email>hfarhat@ch-versailles.fr</email>
    </contact>
    <investigator>
      <last_name>Hassan FARHAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Chartres</name>
      <address>
        <city>Le Coudray</city>
        <zip>28630</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Bicetre</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier LAMBOTTE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier LAMBOTTE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Lens</name>
      <address>
        <city>Lens</city>
        <zip>62307</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela ROBU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Daniela ROBU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Vincent</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal LAURENT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascal LAURENT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck MORSCHHAUSER, MD</last_name>
      <email>franck.morschhauser@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Franck MORSCHHAUSER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique BORDESSOULE, MD</last_name>
      <email>bordessoule.URCH@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique BORDESSOULE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste Eugène André</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolae Claudiu PLESA, MD</last_name>
      <email>n.plesa@clinique-mutualiste-lyon.com</email>
    </contact>
    <investigator>
      <last_name>Nicolae Claudiu PLESA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de la Sauvegarde</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle MOULLET, MD</last_name>
      <email>i.moullet@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle MOULLET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine SEBBAN, MD</last_name>
      <email>catherine.sebban@lyon.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine SEBBAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital des Chanaux</name>
      <address>
        <city>Macon</city>
        <zip>71108</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amine BELHABRI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Amine BELHABRI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Mantes</name>
      <address>
        <city>Mantes-la-Jolie</city>
        <zip>78200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane COSO, MD</last_name>
      <email>cosod@ipc.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Diane COSO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CH de Meaux</name>
      <address>
        <city>Meaux</city>
        <zip>77100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wajed ABARAH-ATASI, MD</last_name>
      <email>w-abarah@ch-meaux.fr</email>
    </contact>
    <investigator>
      <last_name>Wajed ABARAH-ATASI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Marc Jacquet</name>
      <address>
        <city>Melun</city>
        <zip>77011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire KULEKCI, MD</last_name>
      <email>claire.kulekci@ch-melun.fr</email>
    </contact>
    <investigator>
      <last_name>Claire KULEKCI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Notre Dame du Bon Secours</name>
      <address>
        <city>Metz</city>
        <zip>57038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CARASSOU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe CARASSOU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - St Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centre Azureen de Cancerologie</name>
      <address>
        <city>Mougins</city>
        <zip>06250</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CH de Mulhouse</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Claude EISENMANN, MD</last_name>
      <email>eisenmannj@ch-mulhouse.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Claude EISENMANN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Oncologie de Gentilly</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge BOLOGNA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Serge BOLOGNA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Américain Paris</name>
      <address>
        <city>Neuilly sur Seine</city>
        <zip>92202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fréderic PEYRADE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric PEYRADE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel KARSENTI, MD</last_name>
      <email>karsenti.jm@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel KARSENTI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine THIEBLEMONT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine THIEBLEMONT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malek AOUDJHANE, MD</last_name>
      <email>malek.aoudjhane@sat.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Malek AOUDJHANE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zora MARJANOVIC, MD</last_name>
      <email>zora.marjanovic@sat.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Zora MARJANOVIC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75248</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fréderique KUHNOWSKI, MD</last_name>
      <email>frederique.kuhnowski@curie.net</email>
    </contact>
    <investigator>
      <last_name>Fréderique KUHNOWSKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean GABARRE, MD</last_name>
      <email>jean.gabarre@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean GABARRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard DELARUE, md</last_name>
    </contact>
    <investigator>
      <last_name>Richard DELARUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Haut Lévêque - Centre François Magendie</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hôpital LYON SUD</name>
      <address>
        <city>Pierre Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand COIFFIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand COIFFIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent DELWAIL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vincent DELWAIL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Rene Dubos</name>
      <address>
        <city>Pontoise</city>
        <zip>95303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugo GONZALEZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hugo GONZALEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Région d'Annecy</name>
      <address>
        <city>Pringy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernadette CORRONT, MD</last_name>
      <email>bcorront@ch-annecy.fr</email>
    </contact>
    <investigator>
      <last_name>Bernadette CORRONT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain DELMER, MD</last_name>
      <email>adelmer@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Alain DELMER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thierry LAMY-DE-LA-CHAPELLE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry LAMY-DE-LA-CHAPELLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Roubaix</name>
      <address>
        <city>Roubaix</city>
        <zip>59100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abir FAWAZ, MD</last_name>
      <email>abir.fawaz@ch-roubaix.fr</email>
    </contact>
    <investigator>
      <last_name>Abir FAWAZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé TILLY</last_name>
    </contact>
    <investigator>
      <last_name>Hervé TILLY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mathilde</name>
      <address>
        <city>Rouen</city>
        <zip>76100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hôpital René Huguenin</name>
      <address>
        <city>Saint Cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie GLAISNER, MD</last_name>
      <email>sylvie.glaisner@curie.net</email>
    </contact>
    <investigator>
      <last_name>Sylvie GLAISNER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut de cancérologie de la Loire</name>
      <address>
        <city>Saint Priest en Jarez</city>
        <zip>42271</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme CORNILLON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jérôme CORNILLON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Saint-Brieuc - Hôpital Yves Le Foll</name>
      <address>
        <city>Saint-Brieuc</city>
        <zip>22023</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent LAUNAY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vincent LAUNAY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc-Matthieu FORNECKER, MD</last_name>
      <email>luc-matthieu.fornecker@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Luc-Matthieu FORNECKER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux du Leman</name>
      <address>
        <city>Thonon-les-Bains</city>
        <zip>74203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria DIAZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Maria DIAZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte Musse</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudine SOHN, MD</last_name>
      <email>claudine.sohn@ch-toulon.fr</email>
    </contact>
    <investigator>
      <last_name>Claudine SOHN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Tours - Hôpital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hélène MONJANEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène MONJANEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Troyes</name>
      <address>
        <city>Troyes</city>
        <zip>10003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia ALI AMMAR, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nadia ALI AMMAR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno ANGLARET, MD</last_name>
      <email>bruno.anglaret@ch-valence.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno ANGLARET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Brabois</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre FEUGIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre FEUGIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe FERME, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christophe FERME, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 8, 2016</lastchanged_date>
  <firstreceived_date>January 14, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
    <mesh_term>Lymphoma, B-Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
